Back to Browse Journals » Journal of Neurorestoratology » Volume 1

Neurorestoratology: one of the most promising new disciplines at the forefront of neuroscience and medicine

Authors Huang H, Sharma HS

Received 17 August 2013

Accepted for publication 19 August 2013

Published 29 October 2013 Volume 2013:1 Pages 37—41

DOI https://doi.org/10.2147/JN.S47592

Checked for plagiarism Yes

Hongyun Huang,1 Hari Shanker Sharma2

1Department of Neurosurgery, Beijing Rehabilitation Hospital, Capital Medical University, Beijing, People's Republic of China; 2Laboratory of Cerebrovascular Research, Department of Surgical Sciences, Anesthesiology and Intensive Care Medicine, University Hospital, Uppsala University, Sweden

Neurorestoratology is a new and emerging distinct discipline put forward on the basis of nervous restorable (neurorestorable) theory, which states that nerve damage to the central nervous system (CNS) can be restored. Neurorestorable theory in CNS was proposed by Huang et al based on clinical achievements obtained from cell-based neurorestorative therapy1.  Neurorestoratology, same as neurology, neurosurgery, neurorehabilitation, etc is a distinct discipline in neuroscience and medicine. The Beijing Declaration of International Association of Neurorestoratology (IANR) determined its definition in 2009.2 The aim of neurorestoratology is to restore or promote recovery of damaged or lost neuronal functions. As depicted in Figure 1,3 it can clearly be seen that there was a blank space – indicated by the question mark in the figure – that needed to be filled with a new discipline, neurorestoratology, so it can be likened to an inexorable biological law and its development to a natural process quite similar to that of the periodic law of chemistry discovered and proposed by Dmitri Mendeleev. In recent years, neurorestoratology has become one of the most interesting core areas of neuroscience and medicine worldwide, representing a novel aspect of translational medicine.

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 

 

Other articles by this author:

2016 yearbook of neurorestoratology

Huang H, Mao G, Feng S, Chen L

Journal of Neurorestoratology 2017, 5:111-115

Published Date: 15 June 2017

Olfactory ensheathing cell transplantation for a patient with chronic sciatic nerve injury

Zhang F, Meng XZ, Lu F, Liu AX, Huang HY

Journal of Neurorestoratology 2017, 5:1-4

Published Date: 28 December 2016

Beijing Declaration of International Association of Neurorestoratology

Young W, AlZoubi ZM, Saberi H, Sharma A, Muresanu D, Feng S, Chen L, Huang H

Journal of Neurorestoratology 2015, 3:121-122

Published Date: 13 November 2015

Progress and challenges with clinical cell therapy in neurorestoratology

Huang H, Mao G, Chen L, Liu A

Journal of Neurorestoratology 2015, 3:91-95

Published Date: 13 April 2015

Developmental history of neurorestoratology

Huang HY, Chen L, Sanberg PR

Journal of Neurorestoratology 2015, 3:31-38

Published Date: 11 February 2015

Neurorestorative process, law, and mechanisms

Huang H, Chen L

Journal of Neurorestoratology 2015, 3:23-30

Published Date: 2 February 2015

Readers of this article also read:

Emerging and future therapies for hemophilia

Carr ME, Tortella BJ

Journal of Blood Medicine 2015, 6:245-255

Published Date: 3 September 2015

Acquired hemophilia A: emerging treatment options

Janbain M, Leissinger CA, Kruse-Jarres R

Journal of Blood Medicine 2015, 6:143-150

Published Date: 8 May 2015

A new recombinant factor VIII: from genetics to clinical use

Santagostino E

Drug Design, Development and Therapy 2014, 8:2507-2515

Published Date: 12 December 2014

Second case report of successful electroconvulsive therapy for a patient with schizophrenia and severe hemophilia A

Saito N, Shioda K, Nisijima K, Kobayashi T, Kato S

Neuropsychiatric Disease and Treatment 2014, 10:865-867

Published Date: 16 May 2014

Green synthesis of water-soluble nontoxic polymeric nanocomposites containing silver nanoparticles

Prozorova GF, Pozdnyakov AS, Kuznetsova NP, Korzhova SA, Emel’yanov AI, Ermakova TG, Fadeeva TV, Sosedova LM

International Journal of Nanomedicine 2014, 9:1883-1889

Published Date: 16 April 2014

Cross-linked acrylic hydrogel for the controlled delivery of hydrophobic drugs in cancer therapy

Deepa G, Thulasidasan AK, Anto RJ, Pillai JJ, Kumar GS

International Journal of Nanomedicine 2012, 7:4077-4088

Published Date: 27 July 2012

Crystallization after intravitreal ganciclovir injection

Pitipol Choopong, Nattaporn Tesavibul, Nattawut Rodanant

Clinical Ophthalmology 2010, 4:709-711

Published Date: 14 July 2010